The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 29, 2026 | Mohideen Pharis | Chief Medical Officer | Sell(S) | 534 | $4.86 | $3K |
| Jan 12, 2026 | Baker Julian | Director | Option exercise(M) | 25.0M | — | $0 |
| Jan 12, 2026 | Baker Julian | Director | Option exercise(M) | 25.0M | — | $0 |
| Jan 12, 2026 | Baker Julian | Director | Option exercise(M) | 2.3M | — | $0 |
| Jan 12, 2026 | Baker Julian | Director | Option exercise(M) | 2.3M | — | $0 |
| Dec 18, 2025 | EPIC Bpifrance | Insider | Sell(S) | 1.3M | $4.19 | $5.4M |
| Dec 17, 2025 | EPIC Bpifrance | Insider | Sell(S) | 40K | $5.28 | $211K |
| Dec 17, 2025 | EPIC Bpifrance | Insider | Sell(S) | 2.0M | $4.84 | $9.9M |
| Nov 21, 2025 | Tasse Daniel | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 964K | — | $0 |
| Nov 21, 2025 | Mohideen Pharis | Chief Medical Officer | Sell(S) | 2K | $2.77 | $4K |
| Nov 21, 2025 | Mohideen Pharis | Chief Medical Officer | Grant(A) | 44K | — | $0 |
| Nov 21, 2025 | Mohideen Pharis | Chief Medical Officer | Grant(A) | 253K | — | $0 |
| Nov 21, 2025 | Boucinha Virginie | Chief Financial Officer | Grant(A) | 32K | — | $0 |
| Nov 21, 2025 | Boucinha Virginie | Chief Financial Officer | Grant(A) | 192K | — | $0 |
| Nov 21, 2025 | Trapp Kevin Michael | Chief Commercial Officer | Grant(A) | 55K | — | $0 |
| Nov 21, 2025 | Trapp Kevin Michael | Chief Commercial Officer | Grant(A) | 316K | — | $0 |
| Nov 20, 2025 | Mohideen Pharis | Chief Medical Officer | Sell(S) | 6K | $2.88 | $19K |
| Jul 29, 2025 | Mohideen Pharis | Chief Medical Officer | Sell(S) | 464 | $2.22 | $1K |
| May 22, 2025 | Mohideen Pharis | Chief Medical Officer | Sell(S) | 397 | $1.84 | $730 |
| Mar 27, 2025 | Baker Brothers Life Sciences LP | Director, 10% Owner | Grant(A) | 2.3M | — | — |
| Mar 27, 2025 | Baker Brothers Life Sciences LP | Director, 10% Owner | Grant(A) | 2.3M | — | — |
| Mar 27, 2025 | Baker Brothers Life Sciences LP | Director, 10% Owner | Grant(A) | 25.0M | — | — |
| Mar 27, 2025 | Baker Brothers Life Sciences LP | Director, 10% Owner | Grant(A) | 25.0M | — | — |
| Jan 30, 2025 | Mohideen Pharis | Chief Medical Officer | Sell(S) | 600 | $0.85 | $510 |
| Dec 4, 2024 | Tasse Daniel | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 813K | — | $0 |
| Nov 25, 2024 | Mohideen Pharis | Chief Medical Officer | Sell(S) | 565 | $0.57 | $322 |
| Nov 22, 2024 | Mohideen Pharis | Chief Medical Officer | Sell(S) | 342 | $0.53 | $181 |
| Nov 21, 2024 | Boucinha Virginie | Chief Financial Officer | Grant(A) | 19K | — | $0 |
| Nov 21, 2024 | Boucinha Virginie | Chief Financial Officer | Grant(A) | 113K | — | $0 |
| Nov 21, 2024 | Mohideen Pharis | Chief Medical Officer | Grant(A) | 35K | — | $0 |
| Nov 21, 2024 | Mohideen Pharis | Chief Medical Officer | Sell(S) | 2K | $0.54 | $1K |
| Nov 21, 2024 | Mohideen Pharis | Chief Medical Officer | Grant(A) | 215K | — | $0 |
| Jul 29, 2024 | Mohideen Pharis | Chief Medical Officer | Sell(S) | 2K | $0.98 | $2K |
| May 24, 2024 | Mohideen Pharis | Chief Medical Officer | Sell(S) | 660 | $1.36 | $898 |
| May 22, 2024 | Mohideen Pharis | Chief Medical Officer | Sell(S) | 382 | $1.38 | $527 |
| Mar 8, 2024 | Tasse Daniel | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 17K | $0.83 | $14K |
| Feb 6, 2024 | Ndu Adora | Director | Buy(P) | 2K | $0.89 | $2K |
| Nov 22, 2023 | Mohideen Pharis | Chief Medical Officer | Sell(S) | 2K | $1.74 | $4K |
| Nov 20, 2023 | Mohideen Pharis | Chief Medical Officer | Grant(A) | 35K | — | $0 |
| Nov 20, 2023 | Mohideen Pharis | Chief Medical Officer | Grant(A) | 215K | — | $0 |
| Nov 20, 2023 | Tasse Daniel | Chief Executive Officer, Director | Grant(A) | 807K | — | $0 |
| Nov 20, 2023 | Boucinha Virginie | Chief Financial Officer | Grant(A) | 19K | — | $0 |
| Nov 20, 2023 | Boucinha Virginie | Chief Financial Officer | Grant(A) | 113K | — | $0 |
| Aug 25, 2023 | Morris Timothy E | Director | Buy(P) | 12K | $1.52 | $18K |
| Aug 1, 2023 | Soland Daniel B | Director | Buy(P) | 15K | $1.62 | $24K |
| May 24, 2023 | Mohideen Pharis | Chief Medical Officer | Sell(S) | 469 | $3.54 | $2K |
| Nov 24, 2022 | Mohideen Pharis | Chief Medical Officer | Sell(S) | 2K | $2.88 | $5K |
| Nov 21, 2022 | Robitaille Sebastien | Chief Financial Officer | Grant(A) | 8K | — | $0 |
| Nov 21, 2022 | Robitaille Sebastien | Chief Financial Officer | Grant(A) | 65K | — | $0 |
| Nov 21, 2022 | Mohideen Pharis | Chief Medical Officer | Grant(A) | 18K | — | $0 |
| Nov 21, 2022 | Mohideen Pharis | Chief Medical Officer | Grant(A) | 115K | — | $0 |
| Nov 21, 2022 | Tasse Daniel | Chief Executive Officer, Director | Grant(A) | 764K | — | $0 |
| Jul 29, 2022 | Mohideen Pharis | Chief Medical Officer | Grant(A) | 10K | — | $0 |
| Jul 29, 2022 | Mohideen Pharis | Chief Medical Officer | Grant(A) | 100K | — | $0 |
| Jun 13, 2022 | Baker Bros. Advisors (GP) LLC | Director, 10% Owner | Grant(A) | 10.6M | — | — |
| Jun 13, 2022 | Baker Bros. Advisors (GP) LLC | Director, 10% Owner | Grant(A) | 1.3M | — | — |
| Jun 13, 2022 | Baker Bros. Advisors (GP) LLC | Director, 10% Owner | Grant(A) | 1.4M | — | — |
| Jun 13, 2022 | Baker Bros. Advisors (GP) LLC | Director, 10% Owner | Grant(A) | 11.7M | — | — |
| Nov 22, 2021 | Robitaille Sebastien | Chief Financial Officer | Grant(A) | 5K | — | $0 |
| Nov 22, 2021 | Robitaille Sebastien | Chief Financial Officer | Grant(A) | 51K | — | $0 |
| Nov 22, 2021 | Mohideen Pharis | Chief Medical Officer | Grant(A) | 9K | — | $0 |
| Nov 22, 2021 | Mohideen Pharis | Chief Medical Officer | Grant(A) | 95K | — | $0 |
| Nov 22, 2021 | Tasse Daniel | Chief Executive Officer, Director | Grant(A) | 274K | — | $0 |
| Jun 10, 2021 | Soland Daniel B | Director | Buy(P) | 7K | $7.12 | $49K |
| Jun 10, 2021 | Ndu Adora | Director | Buy(P) | 7K | $7.12 | $49K |
| Jun 10, 2021 | Morris Timothy E | Director | Buy(P) | 7K | $7.12 | $49K |
| Jun 10, 2021 | Monges Viviane | Director | Buy(P) | 5K | $7.12 | $36K |
| Jun 10, 2021 | De Rosen Michel | Director | Buy(P) | 7K | $7.12 | $49K |
| Jun 10, 2021 | Rao Madduri Ravin | Director | Buy(P) | 7K | $7.12 | $49K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).